DynaMed is a clinical reference and decision support platform published by EBSCO, covering more than 3,400 clinical topics across all major specialties. Content is maintained by approximately 500 practicing clinicians and updated daily through systematic surveillance of over 500 medical journals. Each recommendation includes explicit levels of evidence and grades of recommendation — a transparency feature that distinguishes it from competitors relying on narrative authority.
DynaMed has won Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025), making it the most consistently recognized platform in the category. The DynaMedex bundle adds Micromedex drug information — one of the most widely used medication databases in hospital pharmacy — creating a combined disease-and-drug reference that is difficult to match. In 2024, EBSCO launched Dyna AI, a generative AI layer that delivers conversational answers grounded in DynaMed's curated content.
At $399/year without AI ($475/year with Dyna AI), DynaMed is meaningfully less expensive than UpToDate ($559/year) for comparable depth of content. EHR integration is available via HL7 Infobutton and toolbar links, and the mobile app supports iOS and Android with offline access. The platform also offers CME/MOC credit tracking for every search. DynaMed's main limitation is brand recognition: despite strong clinical content and repeated KLAS wins, it remains less well-known than UpToDate among practicing physicians.